Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin

<div>Relationships between an index of glycemic variability (J-INDEX) and glycated hemoglobin after treatment, in the case of vildagliptin (a) and placebo (b). Variables were logarithmically transformed.</div>

International Journal of Endocrinology

fig2

Figure 2

Figure 2: Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin 

Figure 2 | Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin 